---
title: "Akari治疗 (AKTX.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/AKTX.US/norm.md"
symbol: "AKTX.US"
name: "Akari治疗"
parent: "https://longbridge.com/zh-CN/quote/AKTX.US.md"
datetime: "2026-05-21T03:42:26.555Z"
locales:
  - [en](https://longbridge.com/en/quote/AKTX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AKTX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AKTX.US/norm.md)
---

# Akari治疗 (AKTX.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -9.74 | -4.91 | -7.84 | -2.41 | -5.43 |
| ROE | -270.77% | -83.08% | -106.02% | -32.02% | -67.40% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -14.46M | -5.30M | -6.40M | -1.90M | -3.71M |
| 营业利润 | -3.63M | -3.23M | -2.22M | -3.12M | -3.52M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 33.89M | 47.89M | 45.38M | 50.91M | 50.96M |
| 权益乘数 | 2.36 | 1.69 | 2.00 | 1.99 | 2.34 |
| 每股净资产 | 12.56 | 25.03 | 27.82 | 31.40 | 30.12 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 2.77M | 5.20M | 2.48M | 2.71M | 2.58M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | - | - | - | - | - |
| 净债务 | -2.04M | -4.45M | -267000.00 | -1.16M | -736000.00 |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -2.49M | -3.04M | -2.12M | -3.26M | -2.15M |
| 投资现金流 | - | - | - | - | - |
| 融资现金流 | 53000.00 | 5.76M | 1.90M | 3.38M | 2.13M |
| 自由现金流 | -1.74M | -3.20M | -2.72M | -4.52M | 808875.00 |
| 现金流充裕率 | -1842.96% | -2492.62% | -1050.00% | -1521.50% | -418.29% |
| 举债与偿债 | - | 0.0000 | 2.10M | - | - |
| 资本支出 | - | - | - | - | - |